REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 1 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $63,000 | +293.8% | 123,000 | +8.8% | 0.03% | +314.3% |
| Q4 2016 | $16,000 | -20.0% | 113,000 | +21.5% | 0.01% | -30.0% |
| Q3 2016 | $20,000 | -4.8% | 93,000 | +12.0% | 0.01% | -9.1% |
| Q2 2016 | $21,000 | -22.2% | 83,000 | 0.0% | 0.01% | -26.7% |
| Q1 2016 | $27,000 | -10.0% | 83,000 | 0.0% | 0.02% | -11.8% |
| Q4 2015 | $30,000 | -30.2% | 83,000 | 0.0% | 0.02% | -26.1% |
| Q3 2015 | $43,000 | -14.0% | 83,000 | 0.0% | 0.02% | -14.8% |
| Q2 2015 | $50,000 | -18.0% | 83,000 | 0.0% | 0.03% | -18.2% |
| Q1 2015 | $61,000 | +5.2% | 83,000 | 0.0% | 0.03% | +6.5% |
| Q4 2014 | $58,000 | -13.4% | 83,000 | 0.0% | 0.03% | -8.8% |
| Q3 2014 | $67,000 | -6.9% | 83,000 | 0.0% | 0.03% | -12.8% |
| Q2 2014 | $72,000 | -20.0% | 83,000 | 0.0% | 0.04% | -29.1% |
| Q1 2014 | $90,000 | +114.3% | 83,000 | 0.0% | 0.06% | +111.5% |
| Q4 2013 | $42,000 | +10.5% | 83,000 | 0.0% | 0.03% | +13.0% |
| Q3 2013 | $38,000 | +2.7% | 83,000 | 0.0% | 0.02% | 0.0% |
| Q2 2013 | $37,000 | – | 83,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 20,000 | $57,000 | 0.02% |